Tirzepatide (LY3298176): Research Reference

Research Use Only. This page is a technical reference for in-vitro laboratory research. Reserve Research compounds are not for human or veterinary use, and nothing here is guidance for administration of any kind.

In simple words

Tirzepatide is a chain of 39 amino acids. It is made in a lab. Amino acids are the building blocks of proteins. It has a fatty tail too. The tail helps it last longer.

Cells have switches on the outside. Tirzepatide can turn on two kinds of switches. Their names are GIP and GLP-1. Scientists use it in the lab to see how these switches send signals into cells.

Reserve Research sells tirzepatide only for lab research. See Tirzepatide on our product page →

Tirzepatide (development code LY3298176) is a synthetic, lipidated 39-amino-acid peptide that activates two class B G-protein-coupled receptors: the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R). It was developed by Eli Lilly and Company on a GIP-derived backbone. Two α-aminoisobutyric acid (Aib) residues resist DPP-4 cleavage, and a C20 fatty diacid on lysine 20 binds serum albumin. Its CAS number is 2023788-19-2, its formula is C225H348N48O68, and its molecular weight is about 4,813.5 g/mol.

TypeLipidated peptide, 39 aa
CAS2023788-19-2
Mol. weight≈4,813.5 g/mol
TargetsGIPR + GLP-1R

Tirzepatide key facts

Name Tirzepatide
Development code LY3298176
Compound class Synthetic lipidated peptide; dual GIP receptor / GLP-1 receptor agonist
Length 39 amino acids, C-terminal amide
Sequence Y-Aib-E-G-T-F-T-S-D-Y-S-I-Aib-L-D-K-I-A-Q-K*-A-F-V-Q-W-L-I-A-G-G-P-S-S-G-A-P-P-P-S-NH2 (K* = lipidated lysine 20)
Lipidation C20 fatty diacid on the lysine-20 side chain, attached through a γ-glutamic acid and two 8-amino-3,6-dioxaoctanoic acid (AEEA) spacer units
CAS number 2023788-19-2
Molecular formula C225H348N48O68
Molecular weight ≈4,813.5 g/mol (monoisotopic ≈4,810.5 Da)
Receptor targets GIPR and GLP-1R (class B GPCRs, Gs/cAMP coupled)
Appearance White to off-white lyophilized powder
Storage (lyophilized) −20 °C, dry, protected from light

Structure

Tirzepatide’s sequence is built mostly on the native GIP peptide, with residues borrowed from GLP-1 and exendin-4 so it can also engage the GLP-1 receptor. Three design features set it apart from the native hormones:

  • Aib at positions 2 and 13. α-Aminoisobutyric acid is a non-coded amino acid. At position 2 it blocks cleavage by dipeptidyl peptidase-4 (DPP-4), which rapidly inactivates native GIP and GLP-1.
  • Lipidated lysine 20. A C20 fatty diacid attached through a hydrophilic linker binds non-covalently to serum albumin, which greatly extends the peptide’s persistence in experimental systems.
  • Exendin-like C-terminus. The -PSSGAPPPS-NH2 tail matches the C-terminal segment of exendin-4.

Mechanism studied in research models

GIPR and GLP-1R are class B G-protein-coupled receptors. Both signal mainly through Gs, which raises intracellular cyclic AMP (cAMP). Tirzepatide’s profile at the two receptors is deliberately unequal:

  • Imbalanced toward GIPR. In the discovery work, tirzepatide bound GIPR with an affinity similar to native GIP, and bound GLP-1R about five-fold more weakly than native GLP-1 (Coskun et al., 2018).
  • Biased at GLP-1R. At the GLP-1 receptor, tirzepatide favors cAMP generation over β-arrestin recruitment and causes less receptor internalization than GLP-1. Willard et al. (2020) describe it as an “imbalanced and biased” dual agonist.
  • Structural basis. Cryo-electron microscopy structures of tirzepatide bound to GIPR and GLP-1R show how one peptide engages both receptors (Zhao et al., 2022).

How tirzepatide compares with related research peptides

Compound Receptors activated Backbone
Native GLP-1 GLP-1R Endogenous hormone
Native GIP GIPR Endogenous hormone
Tirzepatide GIPR + GLP-1R GIP-based, lipidated
Retatrutide GIPR + GLP-1R + glucagon receptor GIP-based, lipidated

Laboratory handling and storage

  • Lyophilized powder: store at −20 °C, sealed and dry, away from light. Let the vial reach room temperature before opening.
  • Solvent: labs commonly reconstitute in sterile bacteriostatic water for multi-use stock solutions. Solubility depends on pH and concentration; vendor data show solubility rising at mildly basic pH.
  • Prepared solutions: keep at 2–8 °C, minimize agitation, and avoid repeated freeze–thaw cycles. Lipidated peptides can stick to some plastics, so low-binding tubes help.

What a tirzepatide certificate of analysis should show

  • Identity: mass spectrometry consistent with ≈4,813.5 g/mol (average) for the intact lipidated peptide.
  • Purity: chromatographic purity reported for the specific batch.
  • Batch traceability: a lot number that matches the vial label.

Each peptide batch listed in our catalog has an independent lab report. You can look up a batch number on our COA verification page.

Frequently asked questions

What is tirzepatide?

Tirzepatide (LY3298176) is a synthetic 39-amino-acid lipidated peptide that activates both the GIP receptor and the GLP-1 receptor. Laboratories use it to study dual incretin-receptor signaling.

What is the CAS number for tirzepatide?

2023788-19-2.

What is the molecular weight and formula of tirzepatide?

C225H348N48O68, with an average molecular weight of about 4,813.5 g/mol.

What receptors does tirzepatide activate?

The GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R). Its activity is weighted toward GIPR, and at GLP-1R it favors cAMP signaling over β-arrestin recruitment.

What is the difference between tirzepatide and retatrutide?

Tirzepatide is a dual agonist (GIPR and GLP-1R). Retatrutide is a triple agonist that also activates the glucagon receptor. Both are lipidated 39-amino-acid peptides built on a GIP-based backbone.

Why does tirzepatide contain Aib?

α-Aminoisobutyric acid (Aib) at position 2 blocks cleavage by the enzyme DPP-4, which quickly breaks down native GIP and GLP-1. A second Aib sits at position 13.

How should tirzepatide be stored?

Store the lyophilized powder at −20 °C, dry and protected from light. Keep reconstituted solutions at 2–8 °C and avoid repeated freeze–thaw cycles.

Is Reserve Research tirzepatide sold for laboratory research only?

Yes. It is sold strictly for in-vitro laboratory research. It is not a drug or supplement, and it is not for human or veterinary use.

Research-grade tirzepatide from Reserve Research

Tirzepatide is supplied as a lyophilized powder in sealed vials, with the current batch’s independent COA available through the product page and /verify. Related: retatrutide reference, cagrilintide reference and bacteriostatic water.

View tirzepatide specifications and batch COA →

References

  1. Coskun T, Sloop KW, Loghin C, et al. Molecular Metabolism. 2018;18:3–14. doi:10.1016/j.molmet.2018.09.009
  2. Willard FS, Douros JD, Gabe MBN, et al. JCI Insight. 2020;5(17):e140532. doi:10.1172/jci.insight.140532
  3. Zhao F, Zhou Q, Cong Z, et al. Nature Communications. 2022;13:1057. doi:10.1038/s41467-022-28683-0
  4. ChEBI entry CHEBI:194186 (tirzepatide): formula, mass and structural description. ebi.ac.uk/chebi

Last reviewed: October 2026. This page summarizes published laboratory literature for reference. It makes no claims about the safety or effectiveness of any compound in humans or animals.

✓ Added to cart View Cart →